Journal
CLINICAL INFECTIOUS DISEASES
Volume 66, Issue 2, Pages 306-311Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/cix744
Keywords
Candida; drug resistance; multiple; fungal; communicable diseases; emerging; infection control
Categories
Funding
- Intramural CDC HHS [CC999999] Funding Source: Medline
Ask authors/readers for more resources
Candida auris is an emerging, multidrug-resistant yeast that can spread in healthcare settings. It can cause invasive infections with high mortality and is difficult to identify using traditional yeast identification methods. Candida auris has been reported in more than a dozen countries, and as of August 2017, 112 clinical cases have been reported in the United States. Candida auris can colonize skin and persist in the healthcare environment, allowing for transmission between patients. Prompt investigation and aggressive interventions, including notification to public health agencies, implementation of contact precautions, thorough environmental cleaning and disinfection, infection control assessments, contact tracing and screening of contacts to assess for colonization, and retrospective review of microbiology records and prospective surveillance for cases at laboratories are all needed to limit the spread of C. auris. This review summarizes the current recommended approach to manage cases and control transmission of C. auris in healthcare facilities.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available